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Abstract
Background: Adequate nodal harvest (≥ 12 lymph nodes) in colorectal cancer has been shown to optimize
staging and proposed as a quality indicator of colorectal cancer care. An audit within a single health district in
Nova Scotia, Canada presented and published in 2002, revealed that adequate nodal harvest occurred in only 22%
of patients. The goal of this current study was to identify factors associated with adequate nodal harvest, and
specifically to examine the impact of the audit and feedback strategy on nodal harvest.
Methods: This population-based study included all patients undergoing resection for primary colorectal cancer in
Nova Scotia, Canada, from 01 January 2001 to 31 December 2005. Linkage of the provincial cancer registry with
other databases (hospital discharge, physician claims data, and national census data) provided clinicodemographic,
diagnostic, and treatment-event data. Factors associated with adequate nodal harvest were examined using
multivariate logistic regression. The specific interaction between year and health district was examined to identify
any potential effect of dissemination of the previously-performed audit.
Results: Among the 2,322 patients, the median nodal harvest was 8; overall, 719 (31%) had an adequate nodal
harvest. On multivariate analysis, audited health district (p < 0.0001), year (p < 0.0001), younger age (p < 0.0001),
non-emergent surgery (p < 0.0001), more advanced stage (p = 0.008), and previous cancer history (p = 0.03) were
associated with an increased likelihood of an adequate nodal harvest. Interaction between year and audited health
district was identified (p = 0.006) such that the increase in adequate nodal harvest over time was significantly
greater in the audited health district.
Conclusions: Improvements in colorectal cancer nodal harvest did occur over time. A published audit
demonstrating suboptimal nodal harvest appeared to be an effective knowledge translation tool, though more
so for the audited health district, suggesting a potentially beneficial effect of audit and feedback strategies.
Background
In Canada, it is estimated there will be 22,500 new cases
of colorectal cancer in 2010. More than 9,100 will die of
the disease, making it the second most common cancer-
causing death [1]. Survival is clearly related to stage of
disease at diagnosis; the status of lymph nodes is a criti-
cal discriminator of stage, particularly in discriminating
patients with stage II and stage III disease [2]. The use
of adjuvant therapies has been clearly shown to improve
survival for stage III patients, but less conclusively for
stage II patients. Thus, nodal status often plays an
important role in determining the need for, and the
potential benefit from, such adjuvant therapy [3-6].
Many studies over the past 15 years have demon-
strated the importance of an adequate nodal harvest in
colorectal cancer, and specifically that node positivity
rates increase with increased nodal harvest [7-12].
Moreover, improved survival among patients with
greater nodal harvests has also been reproducibly
demonstrated [13-18]. Although there exists some varia-
bility in the number of lymph nodes suggested for accu-
rate staging [19], several organizations have advocated
that a minimum of 12 lymph nodes are required.
A minimum of 12 lymph nodes has been approved by
the National Quality Forum as a quality indicator for col-
orectal cancer care, and has subsequently become a focus
for quality and pay for performance initiatives [20].
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in colorectal cancer specimens approximately a decade
ago [12]. This work, published in 2002, demonstrated
that nodal harvest was adequate (≥ 12 lymph nodes) in
only 22% of patients in a single health district. The find-
ings were presented in multiple forums within the speci-
fic institution’s health district as part of an audit and
feedback strategy, over 2001-2003.
The goal of our current study was to identify factors
associated with adequate nodal harvest in the entire pro-
vince of Nova Scotia, and to specifically examine the
impact of our prior audit and feedback strategy on sub-
sequent nodal harvest.
Methods
This population-based study included all patients over
the age of 20 diagnosed with colorectal cancer in the
province of Nova Scotia from January 1
st 2001 to
December 31st 2005, and who underwent resection. The
assembly of this cohort was performed based on a link-
age of the provincial cancer registry with other adminis-
trative databases including hospital discharge data,
physician claims data, and national census data, which is
described in detail elsewhere [21]. This linked dataset
provided clinicodemographic, diagnostic and treatment
data on all patients with a diagnosis of colorectal cancer
in the province.
From this dataset, we included all patients undergoing
surgical resection based on procedure codes (Table 1).
W ee x c l u d e ds t a g eI Vp a t i e n t s( N=3 9 4 ) ,p a t i e n t si n
whom no lymph nodes were identified in the specimen
(N = 75), and patients with rectal cancer receiving preo-
perative long-course radiotherapy with or without
chemotherapy (N = 80) due to its known negative
effect on nodal harvest [22]. The remaining study cohort
was comprised of 2,322 patients. Collaborative staging
was applied to all patients within the cohort [23] and
was the source of nodal harvest information.
In 2002, we published a retrospective chart review
study examining nodal harvest from colorectal cancer
resections within a single Nova Scotia health district
over a four-year period (1998-2001). This work was dis-
seminated via presentations in forums in the health dis-
trict where the study was performed, which was also the
only academic health center in the province. These for-
ums included Pathology Grand Rounds, Multidisciplin-
ary Gastroenterology Rounds, Cancer Centre Clinical
Site Team Tumor Board meeting, and Department of
Surgery Research Day. All such forums were within the
health district where the study was performed. All sur-
geons and pathologists involved in colorectal cancer
care in the health district were exposed to at least one
presentation. These presentations were focused on the
results of the study, and did not advocate for any speci-
fic advance pathologic technique of increasing lymph
node harvest such as fat-clearing xylose. No other pro-
vincial dissemination activities were undertaken. The
study was also presented as an oral presentation at the
Society of Surgery for the Alimentary Tract in June
2002 and was published in the Journal of Gastrointest-
inal Surgery in November 2002 [12]. No other specific
intervention was undertaken to improve nodal harvest
within the province of Nova Scotia over the time period
of the current study (2001-2005).
For the current study, we defined an adequate nodal
h a r v e s ta sa tl e a s t1 2l y m p hn o d e si d e n t i f i e dw i t h i nt h e
Table 1 Surgical procedure codes
Code Description
Canadian Classification of Health Interventions (CCI) codes (2001-onward)
1.NM.87.^^ (except 1.NM.87.BA, 1.NM.87.DA, 1.NM.87.LA) Excision partial, large intestine.
1.NM.89.^^ Excision total, large intestine
1.NM.91.^^ Excision radical, large intestine.
1.NQ.87.^^ (except 1.NQ.87.BA-FA and 1.NQ.87.BA, 1.NQ.87.DA, 1.NQ.87.CA, 1.
NQ.87.PB, 1.NQ.87.PF)
Excision partial, rectum
1.NQ.89.^^ Excision total, rectum
Physicians Billings procedure codes
MASG-57.52 Partial excision of large intestine:Terminal ileum, cecum an
descending colon
MASG-57.53 Right hemicolectomy
MASG-57.55 Left hemicolectomy
MASG-57.59 Other partial excision of large intestine
MASG-57.6 Total colectomy
MASG-60.52 Other anterior resection (rectum)
MISG-60.52A Other anterior resection (rectum)-lower anterior resection
MASG-60.55 Hartmann resection (rectum)
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delivered within nine health districts, all of which have
at least one institution providing surgical treatment for
colorectal cancer. The rate of adequate nodal harvest
according to health district was examined over time. We
used multivariate logistic regression to identify factors
independently associated with nodal harvest. A priori we
planned to examine the interaction between health dis-
trict and year on adequate nodal harvest rates in the
province; this analysis was designed to identify any sig-
nificant disproportionate improvement in nodal harvest
over time in a specific health district. Statistical signifi-
cance was set at p < 0.05 and all analyses were per-
formed using SAS (Durham, North Carolina).
This study received full approval by Capital District
Health Authority Research Ethic Board (#CDHA-RS/
2008-049), and all required procedures related to
patient confidentiality and privacy were maintained.
Given the retrospective administrative database metho-
dology, no patient-level informed consent was
required.
Results
Descriptive characteristics of the study cohort (N =
2,322) are found in Table 2. Of the study patients,
35.2%s resided in the health district in which the audit
and feedback was provided, while 64.8% resided in one
of the other eight health districts. Overall, the median
nodal harvest amongst all patients was eight (mean 9.9;
interquartile range 4-13). Node positivity rates increased
with nodal harvest, as shown in Table 3 (p < 0.0001).
For the entire study cohort, there was an increase in
number of nodes harvested by year (Table 4). According
to the ap r i o r ithreshold of ≥ 12 lymph nodes, 719
(31%) of the 2,322 patients had an adequate nodal har-
vest. Figure 1 depicts the rate of adequate nodal harvest
rates by year, stratified according to audit and feedback
vs. non-audit and feedback health district. There was an
increase in the rate of adequate nodal harvest on uni-
variate analysis over time among both audit and feed-
back (p < 0.0001) and non-audit and feedback (p <
0.0001) health district. This rate increased from 15.3%
in 2001 to 30.0% in 2005 in the non-audit and feedback
health district, whereas within the audited health dis-
trict, the adequate nodal harvest rate rose from 29.4% to
62.3% for the same time period.
T a b l e5s u m m a r i z e st h eu n i v a r i a t ea n dm u l t i v a r i a t e
analyses of factors associated with an adequate nodal har-
vest. Younger age, non-emergent surgery, more advanced
stage, absence of a previous cancer history, and more
recent year were all associated with an increased likeli-
hood of adequate nodal harvest. Controlling for these
factors, patients who underwent surgery within the audit
and feedback health district were 3.23 times more likely
Table 2 Distribution of clinicodemographic characteristics
of the study cohort (N = 2322)
N %
Age (yrs)
20-49 128 5.5
50-64 600 25.8
65-74 646 27.8
≥ 75 948 40.8
Sex
Female 1118 48.1
Male 1204 51.9
Tumor location
Right colon 1010 43.5
Left colon 628 27.0
Rectum 657 28.3
Unknown/NOS 27 1.2
Cancer history
No 1964 84.6
Yes 358 15.4
Surgery
Emergent 436 18.8
Non-emergent 1886 81.2
Stage
I 478 20.6
II 963 41.5
III 846 36.4
Unknown 35 1.5
Grade
Well differentiated 206 8.9
Moderate 1546 66.6
Poorly differentiated 339 14.6
Unknown/NOS 231 9.9
DHA
1 (no audit and feedback) 185 8.0
2 (no audit and feedback) 186 8.0
3 (no audit and feedback) 213 9.2
4 (no audit and feedback) 180 7.8
5 (no audit and feedback) 107 4.6
6 (no audit and feedback) 125 5.4
7 (no audit and feedback) 126 5.4
8 (no audit and feedback) 382 16.5
9 (audit and feedback) 818 35.2
Total 2322 100
Table 3 Association between lymph node harvest (by
quartiles) and incidence of nodal metastases
Lymph node harvest N % with ≥ 1 positive node(s)
1-3 470 16.0%
4-7 576 35.9%*
8-12 584 43.5%*
>12 620 42.9%*
* p<0.0001 compared to 1-3 nodes.
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underwent resection in one of the non-audit and feed-
back health district. Of note, we were unable to assess
hospital volume or type (academic vs. community) in this
multivariate analysis due to significant collinearity with
the audit and feedback health district variable (variance
inflation factor > 10) [24].
When we examined the impact of health district over
time on the adequacy of nodal harvest, there was a sig-
nificant interaction. The improvement in nodal harvest
over time was significantly greater (p = 0.007) within the
audit and feedback health district than the improvement
in the non-audit and feedback health district (i.e.
although a significant improvement was identified in all
health districts, this improvement was significantly
greater in the audit a feedback health district).
Discussion
Although several studies have shown improvement of col-
orectal cancer nodal harvest, there exists no consensus on
mechanism(s) responsible for such improvement [25,26].
Table 4 Number of lymph nodes by year for entire study
cohort (N = 2322)
Year Median Interquartile range Mean
2001 6 3-11 8
2002 8 4-12 8.9
2003 8 5-14 9.9
2004 9 5-15 11.0
2005 9 5-16 11.5
All 8 4-13 9.9
Figure 1 Percentage adequate nodal harvest by year, according to Health District type (N = 2322).
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gest a positive association between audit and feedback on
adequacy of nodal harvest in colorectal cancer.
The use of audit and feedback to improve clinical
practice has been studied across a range of health care
settings, with systematic reviews demonstrating only
modest improvements in practice [27,28]. The effective-
ness of audit and feedback may be greater, however,
when baseline adherence to a recommended practice is
low [28]. In colorectal cancer, prior research has
demonstrated suboptimal nodal harvest [12,29-31], with
Wright and colleagues [32] demonstrating knowledge
‘gaps’ between current and best practices. However, tra-
ditional continuing medical education (CME) has been
shown inadequate at bridging the gap between current
practice and best available evidence [33].
In Ontario, Canada, a multi-faceted CME strategy,
which included didactic teaching, a gastrointestinal
tumour site retreat, informal opinion leadership, perfor-
mance feedback, and development of a synoptic pathol-
ogy report, was associated with improved colon cancer
staging and nodal harvest at one tertiary cancer centre
[34]. Although this overall strategy was effective, its
multimodal nature makes it difficult to determine which
change techniques were of most benefit. A subsequent
Ontario-wide randomized controlled trial demonstrated
that a standardized lecture given by formal opinion lea-
ders improved nodal harvest in colon cancer, but aca-
demic detailing and provision of a toolkit yielded no
further improvements [26].
T h em a j o r i t yo ft h ef a c t o r sw ei d e n t i f i e dt ob ea s s o -
ciated with nodal harvest were consistent with previous
literature. Specifically, an adequate nodal harvest is
more common in right colon lesions, non-emergent sur-
gery, and higher stage lesions [30,35,36]. We identified a
modest association between previous cancer history and
lower rate of adequate nodal harvest, a finding not
reported previously. Although we have no definitive
explanation for this finding, we hypothesize that, at least
in part, it may be related to previous abdominal surgery
in these patients and subsequent associated challenges
in extensive mesenteric resection.
Table 5 Univariate and multivariate analysis of factors associated with an adequate (≥ 12) nodal harvest (N = 2322)
Univariate Multivariate
OR 95% CI p OR 95% CI p
Age 0.0006 < 0.0001
20-49 1 1
50-64 0.78 0.53-1.15 0.82 0.53-1.26
65-74 0.70 0.46-1.00 0.70 0.45-1.07
≥ 75 0.54 0.37-0.78 0.49 0.32-0.75
Sex 0.03 0.11
Female 1 1
Male 0.83 0.69-0.98 0.85 0.70-1.04
Tumor location < 0.0001 < 0.0001
Right colon 1 1
Left colon 0.58 0.47-0.72 0.54 0.42-0.69
Rectum 0.61 0.49-0.76 0.52 0.40-0.66
Unknown/NOS 0.59 0.59-1.41 0.79 0.31-1.97
Cancer history 0.02 0.03
No 1 1
Yes 0.74 0.57-0.95 0.74 0.56-0.98
Year (continuous variable) 1.29 1.20-1.36 < 0.0001 1.36 1.27-1.45 < 0.0001
Surgery 0.02 < 0.0001
Elective 1 1
Emergent 0.75 0.59-0.95 0.60 0.46-0.77
Stage < 0.0001 0.008
I1 1
II 1.89 1.45-2.45 1.93 1.50-2.59
III 2.31 1.78-3.01 2.45 1.83-3.28
Unknown 0.24 0.06-1.02 0.30 0.07-1.33
Health District < 0.0001 < 0.0001
No audit and feedback 1 1
Audit and feedback 2.88 2.40-3.46 3.23 2.65-3.94
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teristics such as volume, academic status, or presence of
multidiciplinary teams may impact on quality of care in
colorectal cancer. We are limited in our ability to fully
evaluate these factors in our study given that the audit
and feedback health district was also the highest volume
centre, the only academic center, and coordinated multi-
disciplinary case conferences in the province.
A major strength of our study is the assessment of
lymph node harvest and associated changes over time for
a 5-year population-based, fully staged cohort of colorec-
tal cancer patients. However, there are some limitations.
Firstly, the methodology of this work involves the use of
linked administrative data, thus limiting the ability to
identify the actual clinical factors contributing to nodal
harvest. The extent and technique of surgical resection
and the specific nodal identification technique used by a
pathologist are examples of such potential contributory
factors that we are unable to examine with our data
sources [37-39]. Specifically, although the audit and feed-
back strategy did not advocate for any specific advanced
techniques of pathologic assessment (e.g. fat-clearing
xylose), we are unable to determine if this occurred. Sec-
ondly, although we have clearly demonstrated an increase
in nodal harvest in the audit and feedback health district,
more marked over time, true causation cannot be proven
in such a study design. Our data limits us in truly deli-
neating the technical changes made (including whether
the improvements were based on surgical or pathological
technique, or both) that improved nodal harvest dispro-
portionately in the audit and feedback health district.
Finally, the acceptance of nodal harvest as a quality indi-
cator of CRC care implies an association with patient
outcome. Neither survival nor recurrence was not evalu-
ated in this study for data availability reasons, but clearly
is of utmost importance and is required in future studies.
Conclusions
In conclusion, this study demonstrated that there were
clear improvements in CRC nodal harvest that occurred
o v e rt h et i m ep e r i o do ft h estudy. Dissemination of a
published audit demonstrating suboptimal nodal harvest
appeared to be an effective tool. This suggests a poten-
tial beneficial effect of audit and feedback strategies to
improve colorectal cancer care.
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